Supernus Pharmaceuticals's total assets for Q2 2025 were $1.38B, an increase of 2.61% from the previous quarter. SUPN total liabilities were $318.50M for the fiscal quarter, a 0.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.